115 related articles for article (PubMed ID: 37948339)
1. Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancer.
Lin Y; Yang Q
Anticancer Drugs; 2024 Feb; 35(2):209-217. PubMed ID: 37948339
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.
Laack E; Köhler A; Kugler C; Dierlamm T; Knuffmann C; Vohwinkel G; Niestroy A; Dahlmann N; Peters A; Berger J; Fiedler W; Hossfeld DK
Ann Oncol; 2002 Oct; 13(10):1550-7. PubMed ID: 12377642
[TBL] [Abstract][Full Text] [Related]
3. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
[TBL] [Abstract][Full Text] [Related]
4. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
McGirt MJ; Lynch JR; Blessing R; Warner DS; Friedman AH; Laskowitz DT
Neurosurgery; 2002 Nov; 51(5):1128-34; discussion 1134-5. PubMed ID: 12383357
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
6. Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.
Guo WJ; Li J; Ling WL; Bai YR; Zhang WZ; Cheng YF; Gu WH; Zhuang JY
World J Gastroenterol; 2002 Jun; 8(3):476-9. PubMed ID: 12046073
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
9. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer.
Van Trappen PO; Ryan A; Carroll M; Lecoeur C; Goff L; Gyselman VG; Young BD; Lowe DG; Pepper MS; Shepherd JH; Jacobs IJ
Br J Cancer; 2002 Aug; 87(5):537-44. PubMed ID: 12189553
[TBL] [Abstract][Full Text] [Related]
10. [Changes in serum vascular endothelial growth factor and matrix metalloproteinase-9 after video-assisted thoracoscopic surgery and thoracotomic Lobectomy in the treatment of patients with non-small cell lung cancer].
Tian W; Tong H; Sun Y; Wu Q; Ma C; Jiao P
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):24-9. PubMed ID: 24398310
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma].
Li YH; Shao JY; Li S; Zou BY; Huang HQ; Guan ZZ
Ai Zheng; 2004 Sep; 23(9):1060-4. PubMed ID: 15363202
[TBL] [Abstract][Full Text] [Related]
12. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T
Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690
[TBL] [Abstract][Full Text] [Related]
13. Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.
Soyama H; Miyamoto M; Matsuura H; Iwahashi H; Kakimoto S; Ishibashi H; Sakamoto T; Hada T; Suminokura J; Takano M
Cancer Chemother Pharmacol; 2020 May; 85(5):941-947. PubMed ID: 32279102
[TBL] [Abstract][Full Text] [Related]
14. [Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer].
Guan KP; Hou SK; Yan Z; Ye HY
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):430-2. PubMed ID: 12895351
[TBL] [Abstract][Full Text] [Related]
15. Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Mihaylova Zh; Ludovini V; Gregorg V; Floriani I; Pistola L; Toffaneti F; Ferraldeschi M; Spreafico A; Ceresoli GL; Bellet M; Darwish S; Tonato M; Raynov J
J BUON; 2007; 12(1):105-11. PubMed ID: 17436410
[TBL] [Abstract][Full Text] [Related]
16. [Clinical research of perioperative serum VEGF and MMP-9 levels in patients with non-small cell lung cancer.].
Hu Y; Li B; Song C
Zhongguo Fei Ai Za Zhi; 2008 Oct; 11(5):734-8. PubMed ID: 20738923
[TBL] [Abstract][Full Text] [Related]
17. Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Liu CJ; Chang KW; Lin SC; Cheng HW
Oral Oncol; 2009 Oct; 45(10):920-5. PubMed ID: 19502103
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma.
Dueñas-González A; López-Graniel C; González A; Gomez E; Rivera L; Mohar A; Chanona G; Trejo-Becerril C; de la Garza J
Am J Clin Oncol; 2003 Feb; 26(1):22-5. PubMed ID: 12576919
[TBL] [Abstract][Full Text] [Related]
20. Clinical Effect of the Combination of Compound Kushen Injection and Gemcitabine on Postoperative Patients with Non-Muscle Invasive Bladder Cancer and Its Influence on Serum-Related Factors.
Dong X; Wang Y; Wang S; Li C; Zhang M; Hou F
Arch Esp Urol; 2023 Nov; 76(9):657-665. PubMed ID: 38053420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
